Samuel S Gidding1, Donald Lloyd-Jones2, Joao Lima3, Bharat Ambale-Venkatesh3, Sanjiv J Shah4, Ravi Shah5, Cora E Lewis6, David R Jacobs7, Norrina B Allen2. 1. Nemours Cardiac Center, A.I. DuPont Hospital for Children, Wilmington, DE (S.S.G.). 2. Department of Preventive Medicine (D.L.-J., N.B.A.), Feinberg Medical School, Northwestern University, Chicago, IL. 3. Department of Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD (J.L., B.A.-V.). 4. Department of Internal Medicine (S.J.S.), Feinberg Medical School, Northwestern University, Chicago, IL. 5. Division of Cardiology, Massachusetts General Hospital, Boston (R.S.). 6. Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham (C.E.L.). 7. School of Public Health University of Minnesota, Minneapolis (D.R.J.).
Abstract
BACKGROUND: Staging criteria for heart failure (HF) range from stage 0 (without risk) to being at risk (stage A) to presence of cardiac structural/functional abnormalities (stage B) to symptomatic/end stage (stages C/D). There are limited data on the prevalence of these stages in early adulthood and predictors of HF stage and symptoms in middle age. METHODS AND RESULTS: The CARDIA study (Coronary Artery Risk Development in Young Adults)-a cohort of generally healthy black and white men and women-collected phenotypic, echocardiographic, and outcomes data at the year 5 and year 30 examinations when participants were 22 to 37 and 47 to 62 years of age. Prevalence of HF stages was calculated and relationship of year 5 stage to year 30 classification and outcomes was assessed. At year 5, 2189 participants had complete data. Prevalence of HF stage A/B increased from 24% to 76% in black men, from 13% to 64% in white men, from 34% to 81% in black women, and from 13% to 56% in white women. Blacks were more likely to be in any stage or with morbidity at both time points because of higher risk factor prevalence. Of 33 participants with HF or HF deaths by year 30, 21 (64%) had been in stage A or B at year 5. Only 6 participants at year 5 in stage A (at risk) improved risk status at year 30. CONCLUSIONS: Risk for HF increased in participants from 1990 (age 22-37 years) to 2015 (age 47-62 years). Symptomatic HF or death from HF is associated with HF stage at 22 to 37 years of age. Blacks are disproportionately affected.
BACKGROUND: Staging criteria for heart failure (HF) range from stage 0 (without risk) to being at risk (stage A) to presence of cardiac structural/functional abnormalities (stage B) to symptomatic/end stage (stages C/D). There are limited data on the prevalence of these stages in early adulthood and predictors of HF stage and symptoms in middle age. METHODS AND RESULTS: The CARDIA study (Coronary Artery Risk Development in Young Adults)-a cohort of generally healthy black and white men and women-collected phenotypic, echocardiographic, and outcomes data at the year 5 and year 30 examinations when participants were 22 to 37 and 47 to 62 years of age. Prevalence of HF stages was calculated and relationship of year 5 stage to year 30 classification and outcomes was assessed. At year 5, 2189 participants had complete data. Prevalence of HF stage A/B increased from 24% to 76% in black men, from 13% to 64% in white men, from 34% to 81% in black women, and from 13% to 56% in white women. Blacks were more likely to be in any stage or with morbidity at both time points because of higher risk factor prevalence. Of 33 participants with HF or HF deaths by year 30, 21 (64%) had been in stage A or B at year 5. Only 6 participants at year 5 in stage A (at risk) improved risk status at year 30. CONCLUSIONS: Risk for HF increased in participants from 1990 (age 22-37 years) to 2015 (age 47-62 years). Symptomatic HF or death from HF is associated with HF stage at 22 to 37 years of age. Blacks are disproportionately affected.
Entities:
Keywords:
United States; cohort studies; echocardiography; heart failure
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: C E Lewis; D R Jacobs; H McCreath; C I Kiefe; P J Schreiner; D E Smith; O D Williams Journal: Am J Epidemiol Date: 2000-06-15 Impact factor: 4.897
Authors: Markus Juonala; Costan G Magnussen; Gerald S Berenson; Alison Venn; Trudy L Burns; Matthew A Sabin; Sathanur R Srinivasan; Stephen R Daniels; Patricia H Davis; Wei Chen; Cong Sun; Michael Cheung; Jorma S A Viikari; Terence Dwyer; Olli T Raitakari Journal: N Engl J Med Date: 2011-11-17 Impact factor: 91.245
Authors: Khawaja Afzal Ammar; Steven J Jacobsen; Douglas W Mahoney; Jan A Kors; Margaret M Redfield; John C Burnett; Richard J Rodeheffer Journal: Circulation Date: 2007-03-12 Impact factor: 29.690
Authors: Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley Journal: N Engl J Med Date: 2009-03-19 Impact factor: 91.245
Authors: Mark J Pletcher; Kirsten Bibbins-Domingo; Cora E Lewis; Gina S Wei; Steve Sidney; J Jeffrey Carr; Eric Vittinghoff; Charles E McCulloch; Stephen B Hulley Journal: Ann Intern Med Date: 2008-07-15 Impact factor: 25.391
Authors: Samuel S Gidding; Kiang Liu; Laura A Colangelo; Nakela L Cook; David C Goff; Stephen P Glasser; Julius M Gardin; Joao A C Lima Journal: Circ Cardiovasc Imaging Date: 2013-08-06 Impact factor: 7.792
Authors: Catherine M Loria; Kiang Liu; Cora E Lewis; Stephen B Hulley; Stephen Sidney; Pamela J Schreiner; O Dale Williams; Diane E Bild; Robert Detrano Journal: J Am Coll Cardiol Date: 2007-05-04 Impact factor: 24.094
Authors: Shannon M Dunlay; Véronique L Roger; Jill M Killian; Susan A Weston; Philip J Schulte; Anna V Subramaniam; Saul B Blecker; Margaret M Redfield Journal: JACC Heart Fail Date: 2021-08-11 Impact factor: 12.544
Authors: Arjun Sinha; Deepak K Gupta; Clyde W Yancy; Sanjiv J Shah; Laura J Rasmussen-Torvik; Elizabeth M McNally; Philip Greenland; Donald M Lloyd-Jones; Sadiya S Khan Journal: Circ Heart Fail Date: 2021-02-04 Impact factor: 8.790
Authors: William V Bobo; Euijung Ryu; Tanya M Petterson; Kandace Lackore; Yijing Cheng; Hongfang Liu; Laura Suarez; Martin Preisig; Leslie T Cooper; Veronique L Roger; Jyotishman Pathak; Alanna M Chamberlain Journal: J Comorb Date: 2020-12-24
Authors: Pei-Pei Zheng; Si-Min Yao; Jing Shi; Yu-Hao Wan; Di Guo; Ling-Ling Cui; Ning Sun; Hua Wang; Jie-Fu Yang Journal: Front Cardiovasc Med Date: 2020-12-10
Authors: Amanda M Perak; Sadiya S Khan; Laura A Colangelo; Samuel S Gidding; Anderson C Armstrong; Cora E Lewis; Jared P Reis; Pamela J Schreiner; Stephen Sidney; Joao A C Lima; Donald M Lloyd-Jones Journal: J Am Soc Echocardiogr Date: 2020-11-17 Impact factor: 5.251
Authors: Donald M Lloyd-Jones; Cora E Lewis; Pamela J Schreiner; James M Shikany; Stephen Sidney; Jared P Reis Journal: J Am Coll Cardiol Date: 2021-07-20 Impact factor: 27.203